Western blotting and reverse transcriptase quantitative polymerase chain reaction (PCR) were performed to assess whether cancer proliferation and malignancy-related pathways (MAPK, NFкB, Wnt, Hif, Hedgehog pathways, and P53) were shifted to a lower malignancy state after RFA + MLT treatment. The gene discussed is TP53; the disease is cancer.